These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7853968)

  • 21. Enzyme replacement treatment in type 1 and type 3 Gaucher's disease.
    Bembi B; Zanatta M; Carrozzi M; Baralle F; Gornati R; Berra B; Agosti E
    Lancet; 1994 Dec; 344(8938):1679-82. PubMed ID: 7996964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment.
    Zimran A; Elstein D; Kannai R; Zevin S; Hadas-Halpern I; Levy-Lahad E; Cohen Y; Horowitz M; Abrahamov A
    Am J Med; 1994 Jul; 97(1):3-13. PubMed ID: 8030654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma lipoprotein responses to enzyme-replacement in Gaucher's disease.
    Cenarro A; Pocovi M; Giraldo P; Garcia-Otin AL; Ordovas JM
    Lancet; 1999 Feb; 353(9153):642-3. PubMed ID: 10030334
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of Gaucher's disease.
    Moscicki RA; Taunton-Rigby A
    N Engl J Med; 1993 May; 328(21):1564; author reply 1567-8. PubMed ID: 8373459
    [No Abstract]   [Full Text] [Related]  

  • 25. Gaucher's disease: a review.
    Morales LE
    Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic malpractice in the treatment of Gaucher's disease.
    Beutler E
    Am J Med; 1994 Jul; 97(1):1-2. PubMed ID: 8030649
    [No Abstract]   [Full Text] [Related]  

  • 27. Splenic abscess in a patient with type 3 Gaucher's disease receiving enzyme replacement therapy.
    Maclean K; Wilson MJ
    J Pediatr; 1999 Feb; 134(2):245-7. PubMed ID: 9931539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.
    Mistry PK; Davies S; Corfield A; Dixon AK; Cox TM
    Q J Med; 1992 Jul; 83(303):541-6. PubMed ID: 1484931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
    MacKenzie JJ; Amato D; Clarke JT
    CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imiglucerase treatment in Gaucher's disease.
    Shah U; Nadeem N; Husen Y; Fadoo Z
    J Ayub Med Coll Abbottabad; 2007; 19(2):56-9. PubMed ID: 18183722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended interval between enzyme therapy infusions for adult patients with Gaucher's disease type 1.
    Pérez-Calvo J; Giraldo P; Pastores GM; Fernández-Galán M; Martín-Nuñez G; Pocoví M
    J Postgrad Med; 2003; 49(2):127-31. PubMed ID: 12867687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement In Symptoms Of Gaucher's Disease By Enzyme Replacement Therapy.
    Mazher W; Ali J; Abubakar S; Basar S; Murtaza G
    J Ayub Med Coll Abbottabad; 2018; 30(3):479-481. PubMed ID: 30465391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme replacement therapy in Gaucher's disease.
    Kasturi L; Amin SA
    Indian Pediatr; 2001 Jun; 38(6):686-8. PubMed ID: 11418745
    [No Abstract]   [Full Text] [Related]  

  • 36. IV epoprostenol in Gaucher's disease.
    Elstein D; Zimran A
    Chest; 2000 Jun; 117(6):1821. PubMed ID: 10858430
    [No Abstract]   [Full Text] [Related]  

  • 37. [Persistence of pulmonary lesions in a 6-year-old boy with type I Gaucher's disease treated by alglucerase since the age of 20 months].
    Versteegh C; Avni F; Cuvelier P; Ferster A
    Arch Pediatr; 1998 Dec; 5(12):1341-3. PubMed ID: 9885741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocerebrosidase for treatment of Gaucher's disease: first German long-term results.
    Niederau C; Holderer A; Heintges T; Strohmeyer G
    J Hepatol; 1994 Oct; 21(4):610-7. PubMed ID: 7814809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plant-based oral delivery of β-glucocerebrosidase as an enzyme replacement therapy for Gaucher's disease.
    Shaaltiel Y; Gingis-Velitski S; Tzaban S; Fiks N; Tekoah Y; Aviezer D
    Plant Biotechnol J; 2015 Oct; 13(8):1033-40. PubMed ID: 25828481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy after avascular necrosis of the femur complicating Gaucher's disease.
    Cleary JE; Burke WM; Baxi LV
    Am J Obstet Gynecol; 2001 Jan; 184(2):233-4. PubMed ID: 11174510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.